Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
20 February 2025 - 11:30PM
Feb. 20, 2025-- Tango Therapeutics, Inc. (NASDAQ: TNGX),
a clinical-stage biotechnology company committed to discovering and
delivering the next generation of precision cancer medicines, today
announced that Tango Therapeutics management is scheduled to
participate in three upcoming investment bank conferences. The B
Riley Precision Oncology & Radiopharma Conference will be held
in New York, NY in late February. The Leerink Global Healthcare
Conference and Barclays 27th Annual Global Healthcare Conference
will be held in Miami, FL in March.
B Riley Precision Oncology & Radiopharma
Conference
- Panel participation on Friday,
February 28 at 9:00-10:00 AM ET
- Panel title “Pushing Tumors Over the
Edge with Synthetic Lethality”
Leerink Global Healthcare Conference
- Fireside chat on Wednesday, March 12
at 2:20-2:50 PM ET
- Webcast link HERE
Barclays 27th Annual
Global Healthcare Conference
- Available for 1x1 meetings on
Thursday, March 13
The live webcast for each event will be available under the
"Events & Presentations" tab on the “Investors” page of the
Company's website on the day of the event. A replay of the webcast
will be archived on the Company's website for 90 days following the
presentation.
If you are interested in arranging a 1x1 meeting with
management, please contact your conference representative.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology
company dedicated to discovering novel drug targets and delivering
the next generation of precision medicine for the treatment of
cancer. Using an approach that starts and ends with patients, Tango
leverages the genetic principle of synthetic lethality to discover
and develop therapies that take aim at critical targets in cancer.
For more information, please visit www.tangotx.com.
Investor Contact: Daniella Beckman Chief
Financial Officer, Tango TherapeuticsIR@tangotx.com
Media Contact: Daniella Beckman Chief Financial
Officer, Tango Therapeuticsmedia@tangotx.com
Source: Tango Therapeutics, Inc.
Tango Therapeutics (NASDAQ:TNGX)
Historical Stock Chart
From Jan 2025 to Feb 2025
Tango Therapeutics (NASDAQ:TNGX)
Historical Stock Chart
From Feb 2024 to Feb 2025